Adhesion barrier is a medical implant which can be used to minimize various abnormal internal scarring or adhesions after the surgery by separating the internal tissues and organs while are getting cured.
According to surgeons, the proper surgical technique is very important to reduce any adhesion formation during the surgery and the treatment. From the past one century, many drugs and other substances like animal membranes, gold foil, sheets made of rubber, and Teflon, mineral oil have been used as adjuvant which help in reducing the risk of adhesion formation. Adhesions appear after abdominal and pelvic surgery, which are unavoidable. An adhesion leads to a significant post-surgical morbidity, infertility, bowel obstruction, and chronic pelvic pain or chronic abdominal pain. Surgeons sometimes also apply adhesion barriers while performing abdominal and pelvic surgery to avoid any impediments further.
Market scope and structure analysis:
COVID-19 scenario analysis:
To take care of the infected population the demand for medical supplies is increasing. Respiratory support devices such as atomizer, life-support machine, oxygen generator, and monitor are among the majorly used medical devices in primary clinical treatment. Moreover, COVID-19 has led to a huge surge in demand for medical supplies such as personal protective equipment including masks, gloves, and protective eyeglasses. With a rise in the number of COVID-19 cases worldwide, the need for medical supplies keeps on rising among, both healthcare professionals and civil populations for precautionary measures. Manufacturers of these products have a chance to capitalize on this increased demand for medical supplies to ensure adequate and continuous supply of personal protective equipment in the market.
Owing to such factors, COVID 19 is expected to have a significant impact on the Adhesion barrier market.
Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis
Increase in the knowledge and understanding of adhesions and the issues related to it, various surgical associations and hospitals have been increasing their focus towards the awareness with respect to post-surgical adhesion formations and the availability of anti-adhesive products to control these complications of the patients. These factors are responsible for the swift growth of the adhesion barrier market.
The International Adhesions Society has been providing information about the disorders related to adhesion and its treatment along with precautions which are taken by the patients, surgeons, and other healthcare professionals. IAS is also supporting patients and promotions of various researches for the prevention and treatment of adhesion disorders. These steps taken by IAS will surely increase the awareness and importance of anti-adhesion products in surgical procedures. Additionally, disorders of adhesion and their awareness is also increasing in Asia Pacific countries and is expected to further drive the demand for anti-adhesion products.
Most of the adhesions occur in after the surgical procedures are completed like gynecological, abdominal or pelvic, cardiac surgeries, neurosurgeries, and orthopedic surgeries and so on.
Although surgeons are well-aware of the risks and precaution to be taken for adhesion, they are not willing to use adhesion barriers due to the lack of reliable clinical evidence that supports the safety and efficacy of commercial adhesion barrier products. Moreover, the issues regarding the safety and effectiveness of adhesion barriers the manufacturing companies find it difficult to get marketing approvals for their products from the FDA. In the past few years, the market has also witnessed the discontinuation of many approved adhesion barrier products due to below-par clinical outcomes.
New product launches to flourish the market:
On March 28, 2019, FzioMed enrolled a patient in a clinical study to supports its new gel, Oxiplex which is an adhesive barrier gel to prove the effectiveness and safety of the gel. Oxiplex is an absorbable, synthetic viscoelastic gel that is applied after partial discectomy, to reduce postoperative leg pain, back pain, and neurologic symptoms.
Surge in usage in hospital applications:
Various surgical associations and hospitals are focusing to increase the awareness amongst the population about post-surgical adhesion formation and the available anti-adhesive products to control these complications.
Along with them, IAS is also working to increase the awareness and consumption among the patient and surgeons of adhesion barrier application post-surgery.
Key benefits of the report:
- This study presents the analytical depiction of the global Adhesion barrier industry along with the current trends and future estimations to determine the imminent investment pockets.
- The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global Adhesion barrier market share.
- The current market is quantitatively analyzed to highlight the global Adhesion barrier market growth scenario.
- Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
- The report provides a detailed global Adhesion barrier market analysis based on competitive intensity and how the competition will take shape in coming years.
Questions answered in the Adhesion barrier Market research report:
- What are the leading market players active in the Adhesion barrier market?
- What the current trends will influence the market in the next few years?
- What are the driving factors, restraints, and opportunities in the market?
- What are the projections for the future that would help in taking further strategic steps?
Adhesion Barrier Market Report Highlights
Key Market Players
Integra LifeSciences, Innocoll Holdings, Atrium Medical Corporation, C.R. Bard, MAST Biosurgery, Baxter International, Sanofi, Anika Therapeutics, FzioMed, Johnson & Johnson